Can a simple tech tool boost HIV prevention awareness for women?
NCT ID NCT06785038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a strategy called EMPOWER that uses patient portals to send women educational materials about PrEP (medication that prevents HIV) and lets them easily schedule a doctor visit if interested. The goal is to see if this approach improves women's knowledge about PrEP. The study includes 132 cisgender women who are HIV-negative and have never taken PrEP.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EMPOWER Strategy (behavioral intervention: education, scheduling, counseling support)
- What this could lead to
- If successful, this could provide a practical, scalable way to increase PrEP awareness and uptake among cisgender women in primary care.
- What could go wrong
- This is a small, early-stage behavioral study measuring knowledge, not actual HIV prevention. Results may not generalize to other settings or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREP EDUCATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States